ferric maltol has been researched along with ferric carboxymaltose in 3 studies
| Studies (ferric maltol) | Trials (ferric maltol) | Recent Studies (post-2010) (ferric maltol) | Studies (ferric carboxymaltose) | Trials (ferric carboxymaltose) | Recent Studies (post-2010) (ferric carboxymaltose) |
|---|---|---|---|---|---|
| 23 | 5 | 15 | 471 | 128 | 432 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farland, MZ; Khoury, A; Pagan, KA | 1 |
| Akobeng, AK; Allen, P; Engineer, J; Gordon, M; Hoque, S; Iheozor-Ejiofor, Z; Iqbal, T; Sinopoulou, V | 1 |
| Bokemeyer, B; Domènech, E; Howaldt, S; Martinez, N; Schmidt, C | 1 |
2 review(s) available for ferric maltol and ferric carboxymaltose
| Article | Year |
|---|---|
Ferric Maltol: A New Oral Iron Formulation for the Treatment of Iron Deficiency in Adults.
Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Clinical Trials as Topic; Female; Ferric Compounds; Hematinics; Humans; Inflammatory Bowel Diseases; Male; Maltose; Pyrones; Renal Insufficiency, Chronic; Treatment Outcome | 2021 |
Interventions for treating iron deficiency anaemia in inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Bias; Colitis, Ulcerative; Crohn Disease; Disaccharides; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Fumarates; Hematinics; Humans; Iron Compounds; Maltose; Middle Aged; Placebos; Pyrones; Randomized Controlled Trials as Topic; Young Adult | 2021 |
1 trial(s) available for ferric maltol and ferric carboxymaltose
| Article | Year |
|---|---|
Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial.
Topics: Administration, Intravenous; Administration, Oral; Adult; Anemia, Iron-Deficiency; Female; Ferric Compounds; Hemoglobins; Humans; Inflammatory Bowel Diseases; Male; Maltose; Pyrones; Treatment Outcome | 2022 |